Parvinder Phul

Parvinder Phul, PhD is working as a senior consultant preclinical for drug development and regulatory affairs. Parvinder has significant experience in the early development and licensing of small molecules, radiopharmaceuticals, advanced therapeutics, and biopharmaceutical products.

After finishing his undergraduate degree and then PhD in toxicology at the UCL School of Pharmacy, London, Parvinder started his regulatory career at the UK Medicines and Healthcare products Regulatory Agency (MHRA) where he held the position of a licensing Preclinical Assessor for 14 years.

As a MHRA Preclinical Assessor, Parvinder has carried out preclinical assessment for Marketing Authorisations and Clinical Trial Applications, completing numerous (>25) reviews of new chemical entities sourced as chemicals, biologicals and advanced therapeutics as a Rapporteur in European centralised procedures, in addition to reviewing scientific advice requests and accelerated marketing authorisation applications for the European Medicines Agency (EMA) and the MHRA (EAMs).